Antiestrogenic activities of altenate-substituted polychlorinated dibenzofurans in MCF-7 human breast cancer cells

Cancer Chemotherapy and Pharmacology

Volumn 40, Issue 3, 1997, Pages 239-244

  Sun, Gulan ^a   Safe, Stephen ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Alternate substituted PCDFs; Antiestrogens

Indexed keywords

ANTIESTROGEN; CHLORAMPHENICOL ACETYLTRANSFERASE; ESTRADIOL; ESTROGEN RECEPTOR; POLYCHLORINATED DIBENZOFURAN; BENZOFURAN DERIVATIVE; CHLORINATED DIBENZOFURANS; CYTOCHROME P450 1A1;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; BIOSYNTHESIS; BREAST TUMOR; CELL CULTURE; CELL DIVISION; CHEMISTRY; DRUG EFFECT; FEMALE; METABOLISM; SOIL POLLUTANT;

BENZOFURANS; BREAST NEOPLASMS; CELL DIVISION; CHLORAMPHENICOL O-ACETYLTRANSFERASE; CYTOCHROME P-450 CYP1A1; ESTROGEN ANTAGONISTS; FEMALE; HUMANS; SOIL POLLUTANTS; TUMOR CELLS, CULTURED;

EID: 0030610471     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050653     Document Type: Article

References (43)

1. Astroff B, Safe S (1988) Comparative antiestrogenic activities of 2,3,7,8-tetrachlorodibenzo-p-dioxin and 6-methyl-1,3,8-trichlorodibenzofuran in the female rat. Toxicol Appl Pharmacol 95: 435
2. Astroff B, Safe S (1989) 6-Substituted-1,3,8-trichlorodibenzofurans as 2,3,7,8-tetrachlorodibenzo-p-dioxin antagonists in the rat: structure-activity relationships. Toxicology 59: 285
3. Astroff B, Safe S (1990) 2,3,7,8-Tetrachlorodibenzo-p-dioxin as an antiestrogen: effect on rat uterine peroxidase activity. Biochem Pharmacol 39: 485
4. Astroff B, Safe S (1991) 6-Alkyl-1,3,8-trichlorodibenzofurans as antiestrogens in female Sprague-Dawley rats. Toxicology 69: 187
5. AstrofT B, Zacharewski T, Safe S, Arlotto MP, Parkinson A, Thomas P, Levin W (1988) 6-Methyl-1,3,8-trichlorodibenzofuran as a 2,3,7,8-tetraehlorodibenzo-p-dioxin antagonist: inhibition of the induction of rat cytochrome P-450 isozymes and related monooxygenase activities. Mol Pharmacol 33: 231
6. Astroff B, Rowlands C, Dickerson R, Safe S (1990) 2,3,7,8-Tetrachlorodibenzo-p-dioxin inhibition of 17β-estradiol-induced increases in rat uterine EGF receptor binding activity and gene expression. Mol Cell Endocrinol 72: 247
7. Astroff B, Eldridge B, Safe S (1991) Inhibition of 17β-estradiol-induced and constitutive expression of the cellular protooncogene c-fos by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the female uterus. Toxicol Lett 56: 305
8. Bannister R, Biegel L, Davis D, Astroff B, Safe S (1989) 6-Methyl-1,3,8-trichlorodibenzofuran (MCDF) as a 2,3,7,8-tetrachlorodibenzo-p-dioxin antagonist in C57BL 6 mice. Toxicology 54: 139
9. Bertazzi PA, Pesatori AC, Consonni D, Tironi A, Landi MT, Zocchetti C (1993) Cancer incidence in a population accidentally exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Epidemiology 4: 398
10. Biegel L, Safe S (1990) Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on cell growth and the secretion of the estrogen-induced 34-. 52- and 160-kDa proteins in human breast cancer cells. J Steroid Biochem Mol Biol 37: 725
11. DeVito MJ, Thomas T, Martin E, Umbreit TH, Gallo MA (1992) Antiestrogenic action of 2,3,7,8-tetrachlorodibenzo-p-dioxin: tissue-specific regulation of estrogen receptor in CD1 mice. Toxicol Appl Pharmacol 113: 284
12. Dickerson R, Safe S (1992) The effects of 6-nitro-1,3,8-trichlorodibenzofuran as a partial estrogen in the female rat. Toxicol Appl Pharmacol 113: 55
13. Dickerson R, Howie-Keller L, Safe S (1995) Alkyl polychlorinated dibenzofurans and related compounds as antiestrogens in the female rat uterus: structure-activity studies. Toxicol Appl Pharmacol 135: 287
14. Fernandez P, Burghardt R, Smith R, Nodland K, Safe S (1994) High passage T47D human breast cancer cells: altered endocrine and 2,3,7,8-tetrachlorodibenzo-p-dioxin responsiveness. Eur J Pharmacol 270: 53
15. Gallo MA, Hesse EJ, MacDonald GJ, Umbreit TH (1986) Interactive effects of estradiol and 2,3,7,8-tetrachlorodibenzo-p-dioxin on hepatic cytochrome P-450 and mouse uterus. Toxicol Lett 32: 123
16. Gierthy JE, Lincoln DW (1988) Inhibition of postconfluent focus production in cultures of MCF-7 breast cancer cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Breast Cancer Res 12: 227
17. Gierthy JF, Lincoln DW, Gillespie MB, Seeger JI, Martinez HL, Dickerman HW, Kumar SA (1987) Suppression of estrogen-regulated extracellular plasminogen activator activity of MCF-7 cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Cancer Res 47: 6198
18. Gierthy JF, Bennett JA, Bradley LM, Cutler DS (1993) Correlation of in vitro and in vivo growth suppression of MCF-7 human breast cancer by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Cancer Res 53: 3149
19. Harper N, Wang X, Liu H, Safe S (1994) Inhibition of estrogen-induced progesterone receptor in MCF-7 human breast cancer cells by aryl hydrocarbon (Ah) receptor agonists. Mol Cell Endocrinol 104: 47
20. Harris M, Zacharewski T, Astroff B, Safe S (1989) Partial antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated induction of aryl hydrocarbon hydroxylase by 6-methyl-1,3,8-trichlorodibenzofuran: mechanistic studies. Mol Pharmacol 35: 729
21. Holcomb M, Safe S (1994) Inhibition of 7,12-dimethyl-benzanthracene-induced rat mammary tumor growth by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Cancer Lett 82: 43
22. Klein-Hitpass L, Schorpp M, Wagner U, Ryffel GU (1986) An estrogen-responsive element derived from the 5′-flanking region of the xenopus vitellogenin A2 gene functions in transfected human cells. Cell 46: 1053
23. Kociba RJ, Keyes DG, Beger JE, Carreon RM, Wade CE, Dittenber DA, Kalnins RP, Frauson LE, Park CL, Barnard SD. Hummel RA, Humiston CG (1978) Results of a 2-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in rats. Toxicol Appl Pharmacol 46: 279
24. Krishnan V, Safe S (1993) Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs) and dibenzofurans (PCDFs) as antiestrogens in MCF-7 human breast cancer cells: quantitative structure-activity relationships. Toxicol Appl Pharmacol 120: 55
25. Krishnan V, Porter W, Santostefano M, Wang X, Safe S (1995) Molecular mechanism of inhibition of estrogen-induced cathepsin D gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in MCF-7 cells. Mol Cell Biol 15: 6710
26. Mason G, Sawyer T, Keys B, Bandiera S, Romkes M, Piskorska-Pliszczynska J, Zmudzka B, Safe S (1985) Polychlorinated dibenzofurans (PCDFs): correlation between in vivo and in vitro structure-activity relationships. Toxicology 37: 1
27. Merchant M, Krishnan V, Safe S (1993) Mechanism of action of α-naphthoflavone as an Ah receptor antagonist in MCF-7 human breast cancer cells. Toxicol Appl Pharmacol 120: 179
28. R) human breast cancer cells: a unique aryl hydrocarbon (Ah)-nonresponsive clone. J Biol Chem 269: 11751
29. Pohl RJ, Fouts JR (1980) A rapid method for assaying the metabolism of 7-ethoxyresorufin by microsomal subcellular fractions. Anal Biochem 107: 150
30. Poland A, Knutson JC (1982) 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons. Examinations of the mechanism of toxicity. Annu Rev Pharmacol Toxicol 22: 517
31. Romkes M, Safe S (1988) Comparative activities of 2,3,7,8-tetrachlorodibenzo-p-dioxin and progesterone on antiestrogens in the female rat uterus. Toxicol Appl Pharmacol 92: 368
32. Romkes M, Piskorska-Pliszczynska J, Keys B, Safe S, Fujita T (1987) Quantitative structure-activity relationships: analysis of interactions of 2,3,7,8-tetrachlorodibenzo-p-dioxin and 2-substituted analogues with rat. mouse, guinea pig and hamster cytosolic receptor. Cancer Res 47: 5108
33. Safe S (1990) Polychlorinated biphenyls (PCBs). dibenzo-p-dioxins (PCDDs), dibenzofurans (PCDFs) and related compounds: environmental and mechanistic considerations which support the development of toxic equivalency factors (TEFs). C R C Crit Rev Toxicol 21: 51
34. Safe S (1992) MCDF, 6-methyl-1,3,8-trichlorodibenzofuran. Drugs Future 17: 564
35. Safe S (1995) Modulation of gene expression and endocrine response pathways by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds. Pharmacol Ther 67: 247
36. Safe S, Safe L (1984) Synthesis and characterization of twenty-two purified polychlorinated dibenzofuran congeners. J Agric Food Chem 32: 68
37. Swanson HI, Bradfield CA (1993) The Ah-receptor: genetics, structure and function. Pharmacogenetics 3: 213
38. Umbreit TH, Gallo MA (1988) Physiological implications of estrogen receptor modulation by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Lett 42: 5
39. Umbreit TH, Hesse EJ, MacDonald GJ, Gallo MA (1988) Effects of TCDD-estradiol interactions in three strains of mice. Toxicol Lett 40: 1
40. Whitlock JP Jr (1993) Mechanistic aspects of dioxin action. Chem Res Toxicol 6: 754
41. Yao C, Safe S (1989) 2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced porphyria in genetically inbred mice: partial antagonism and mechanistic studies. Toxicol Appl Pharmacol 100: 208
42. Zacharewski T, Harris M, Biegel L, Morrison V, Merchant M, Safe S (1992) 6-Methyl-1,3,8-trichlorodibenzofuran (MCDF) as an antiestrogen in human and rodent cancer cell lines: evidence for the role of the Ah receptor. Toxicol Appl Pharmacol 13: 311
43. Zacharewski T, Bondy K, McDonell P, Wu ZF (1994) Antiestrogenic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on 17β-estradiol-induced pS2 expression. Cancer Res 54: 2707